Here, we analyzed cell-lines harboring BRAF or RAS mutations (Ba/F3V600E, KG-1a and OCI- AML3), which results in enhanced MAPK signaling activation in a similar way to that observed in ECD patients. Here, BRAF is linked to familial atrioventricular septal defect.